Stryker declares a $0.75 per share quarterly dividend
Stryker (NYSE:SYK) has declared a quarterly dividend of $0.75 per share, payable on January 31, 2023, to shareholders of record as of December 30, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Stryker (NYSE:SYK) has declared a quarterly dividend of $0.75 per share, payable on January 31, 2023, to shareholders of record as of December 30, 2022. This marks a 7.9% increase compared to previous dividends. CEO Kevin Lobo expressed confidence in the company’s growth prospects despite challenging economic conditions, highlighting the steady increase in dividends as a sign of strength. Stryker continues to impact over 100 million patients annually through its innovative medical technologies.
Positive
- Quarterly dividend increased to $0.75 per share.
- 7.9% growth in dividends compared to the prior year.
- Company remains confident in growth despite economic challenges.
Negative
- None.
Details
News Market Reaction – SYK
The recorded move for SYK in the trading session of this news was +2.78%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Kalamazoo, Michigan, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of
“We remain confident in our growth outlook, despite the challenging macroeconomic environment”, said Kevin Lobo, Chair & CEO. “Consequently, we are proceeding with a steady increase in our dividend to
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries please contact:
Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com
For media inquiries please contact:
Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.